“For defined patient groups, there are particular treatment add-ons that may be potentially beneficial – but we know that for the vast majority of patients, more rounds of proven treatment could be more effective,” Prof Tim Child, who chairs the Human Fertilisation and Embryology Authority (HFEA) Scientific and Clinical Advances Advisory Committee, said.
